I see patients at
Address3303 S. Bond Avenue 10th floorPortland, Oregon 97239
Before scheduling your appointment, we recommend you contact your insurance company to verify that the OHSU Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any copayments, co–insurance, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with OHSU providers, your out of pocket liability may be higher. Visit the billing and insurance section of our site for more information.
Dr. Garzotto has a long standing interest in trying to refine the diagnostic approaches to the detection of prostate cancer including incorporation of MRI and novel statistical methods such as machine learning. His research group identified the Viet Nam war-era defoliant, Agent Orange as a risk factor for aggressive prostate cancer. He is considered an expert in the design of novel treatment regimens for locally advanced prostate cancer including combination therapy such as chemoradiation and immuno-hormonal regimens. He is the Chief of the Urology at the Portland VA Medical Center where he also serves as the Lead Investigator for the VA NAVIGATE Program that conducts NCI-sponsored trials for multiple cancer types. Understanding the molecular drivers of cancer is a prime interest of his, as he feels this knowledge is essential to the pursuit of improved outcomes for patients. He has a strong interest in teaching as he feels the future of medicine is dependent on the continued growth in knowledge. He has been awarded the Department Faculty Teacher of the Year Award several times.
- B.S., 1986, Louisiana State University
- M.D., 1990, Louisiana State University School of Medicine
- Urology, University of Florida, 1995
- Urologic Oncology, Memorial Sloan Kettering Cancer Center, 1999
- American Board of Urology, 2001
Memberships and associations
- American Urological Association
- American Society of Clinical Oncology
- American Association of Cancer Research